Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Accumulated Depreciation (2021 - 2025)

Prokidney's (PROK) quarterly Accumulated Depreciation came in at $16.6 million in Q4 2025, up 50.04% year-over-year from $11.0 million in Q4 2024, and up 19.24% quarter-over-quarter from $13.9 million in Q2 2025.

Analysis

Prokidney (PROK) Accumulated Depreciation (2021 - 2025) Analysis & Trends

Prokidney (PROK) has reported Accumulated Depreciation for 5 consecutive years, with $16.6 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Accumulated Depreciation rose 50.04% year-over-year to $16.6 million in Q4 2025; TTM through Dec 2025 was $16.6 million, a 50.04% increase from a year earlier, with the FY2025 full-year figure at $16.6 million, up 50.04% from the prior year.
  • Accumulated Depreciation was $16.6 million for Q4 2025 at Prokidney, up from $13.9 million in the prior quarter.
  • Over five years, Accumulated Depreciation peaked at $16.6 million in Q4 2025 and troughed at $2.3 million in Q4 2021.
  • A 5-year average of $8.5 million and a median of $8.0 million in 2023 frame the typical range for Accumulated Depreciation.
  • Across the five-year window, Accumulated Depreciation surged 108.41% in 2022 and jumped 44.36% in 2024, its largest moves.
  • Over 5 years, Accumulated Depreciation stood at $2.3 million in 2021, then soared by 108.41% to $4.7 million in 2022, then soared by 62.32% to $7.6 million in 2023, then soared by 44.36% to $11.0 million in 2024, then soared by 50.04% to $16.6 million in 2025.
  • The last three Accumulated Depreciation figures came in at $16.6 million (Q4 2025), $13.9 million (Q2 2025), and $12.4 million (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Prokidney 346.07 Mn 346.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 16.55 Mn
Jun 30, 2025 13.88 Mn
Mar 31, 2025 12.41 Mn
Dec 31, 2024 11.03 Mn
Sep 30, 2024 10.57 Mn
Jun 30, 2024 9.40 Mn
Mar 31, 2024 8.44 Mn
Dec 31, 2023 7.64 Mn
Sep 30, 2023 6.77 Mn
Jun 30, 2023 5.98 Mn
Mar 31, 2023 5.33 Mn
Dec 31, 2022 4.71 Mn
Sep 30, 2022 4.09 Mn
Dec 31, 2021 2.26 Mn